Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service to help manage and monitor its clinical trials.
“These offerings can simplify how we manage both operational and study data for in-house as well as outsourced studies,” said Rob Goodwin, vice president of Pfizer Global Product Development, Center of Excellence.
“Clinical teams will be able to access study data through Oracle’s single platform cloud service, eliminating the need to send data back and forth to CROs, saving us time and reducing the cost of our clinical studies.”
By using Health Sciences InForm Cloud Service, Pfizer will be able to take advantage of over 100,000 investigator sites already trained in InForm, while increasing site data satisfaction.
The Health Sciences InForm Cloud Service will enable Pfizer to have greater control over its data and provide measurable efficiency and productivity gains in data management and remote monitoring.
In addition, study templates and library management capabilities within the Health Sciences InForm will enable Pfizer to accelerate the study-build process and result in faster trial implementation.
Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences said: “With more than 15 years of electronic data capture experience in the clinical industry, Oracle Health Sciences helps leading pharmas — such as Pfizer — not only to standardize and optimize their clinical study processes, but also to be prepared with value-based clinical innovation solutions that enable them for the future of data collection.”
Health Sciences InForm Cloud Service includes both Health Sciences InForm and Health Sciences Data Management Workbench (DMW).
Pfizer will also use Oracle Siebel Clinical Trial Management and Monitoring Cloud Service, including Siebel Clinical Trial Management System, Health Sciences Clinical Development Analytics, and risk-based monitoring (RBM) functionality.
This will provide the pharmaceutical company to provide new insights into trial management and help increase efficiency of the monitoring workforce.